Report: Pfizer coronavirus vaccine could be available for kids under 5 in February
The Pfizer-BioNTech coronavirus vaccine could become available for children younger than 5 by the end of February, people familiar with the matter told The Washington Post on Monday. This would be the first vaccine made available for the age group in the United States.
The companies are expected to soon submit a request to the Food and Drug Administration for emergency-use authorization of the vaccine in kids 6 months to 5 years old, the Post reports. Once the FDA receives the application, regulators will begin reviewing the trial data on the two-shot regimen; data on a third shot won't be available until the end of March, at the earliest. The FDA's outside advisers will likely meet on the authorization request in mid-February, the Post reports.
Pfizer and BioNTech shared in December that two doses of its vaccine in 2-, 3-, and 4-year-olds didn't trigger the same type of immune response as seen in teens and adults, but did for children 6 months to 2 years old. During the trial, the kids received two doses of 3-microgram shots — a tenth of the dose given to adults — three weeks apart. Read more at The Washington Post.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published